Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Psychosis and Antipsychotic Drugs: Overview

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

Mania and Antimanic Drugs: Overview

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Management of Insomnia

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Psychotropic-Induced Reversible Cerebral Vasoconstriction Syndrome in a Young Man Taking Sertraline.

The primary care companion for CNS disorders·2026

Same author

Herba Epimedii and Increased Opioid Cravings While on Buprenorphine: A Case Report.

Cureus·2024

Same author

Antisuicidal effect of lithum in bipolar disorder: is there an age-specific effect?

Journal of affective disorders·2023

Same author

Non-pharmacotherapeutic Management of Alcohol Use Disorder in the Alaska Native Population: A Narrative Review.

Cureus·2023

Same author

A Retrospective Analysis of Guanfacine for the Pharmacological Management of Delirium.

Cureus·2023

Same author

Methamphetamine-Induced Catatonia.

The primary care companion for CNS disorders·2022

Search research articles

Related Experiment Video

Updated: May 5, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Psychotropic Management in Cotard Syndrome: Case Reports Supporting Dual Medication Management.

Adam J Fusick¹, Chemar Davis², Steven Gunther¹

¹Mental Health and Behavioral Sciences Service, Department of Psychiatry and Behavioral Neurosciences, James A Haley Veterans Hospital, Tampa, Florida, USA.

Case Reports in Psychiatry

|April 18, 2024

Summary

Cotard syndrome, a rare condition of nihilistic delusions, may be effectively treated with olanzapine and fluoxetine. This combination offers a viable alternative to electroconvulsive therapy (ECT) for severe cases.

More Related Videos

Author Spotlight: Studying Drug Impacts on Brain Signals Using Dual LFP Recording Protocol in Mice

Author Spotlight: Studying Drug Impacts on Brain Signals Using Dual LFP Recording Protocol in Mice

Published on: February 16, 2024

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Related Experiment Videos

Last Updated: May 5, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Author Spotlight: Studying Drug Impacts on Brain Signals Using Dual LFP Recording Protocol in Mice

Author Spotlight: Studying Drug Impacts on Brain Signals Using Dual LFP Recording Protocol in Mice

Published on: February 16, 2024

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Area of Science:

Psychiatry
Neuroscience

Background:

Cotard syndrome is a rare psychiatric condition characterized by delusions of death or non-existence.
Treatment options for Cotard syndrome are limited and often challenging.

Observation:

A literature review identified limited data on the efficacy of specific psychotropic combinations for Cotard syndrome.
Two case studies of elderly male veterans with severe psychotic depression, a condition often associated with Cotard syndrome, were presented.
Both patients' conditions were severe enough to consider electroconvulsive therapy (ECT).

Findings:

The combination of olanzapine and fluoxetine was successfully used to treat two patients with severe psychotic depression, avoiding the need for ECT.
Sparse literature exists regarding this specific medication combination for Cotard syndrome.

Implications:

The combination of olanzapine and fluoxetine is proposed as an effective treatment for Cotard syndrome.
This regimen may serve as an alternative to ECT in severe cases.
Further research is warranted to establish the efficacy of this combination therapy.